Utah Medical Products Inc

UTMD

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0000706698

SEC filings (opens in a new tab)

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Utah Medical Products Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of UTMD: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	90	92	+2
Shares	2.55M	2.57M	+21.5K (+0.8%)
Value	$237.5M	$221.3M	−$16.2M (−6.8%)

New holders (11)

Institutions that held Utah Medical Products Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to UTMD in Q3 2023
Institution	Shares	Value	% of portfolio
Bard Associates Inc	18,181	$1.56M	0.65%
Natixis Advisors, L.P.	12,811	$1.10M	0.00%
Man Group plc	–	$393.7K	0.00%
Winton Group Ltd	3,713	$319.3K	0.03%
Voya Investment Management LLC	3,229	$277.7K	0.00%
Riverwater Partners LLC	2,354	$202.4K	0.18%
Hillsdale Investment Management Inc.	1,400	$120.4K	0.01%
Quadrant Capital Group LLC	128	$11.0K	0.00%
Comerica Bank	115	$9.87K	0.00%
Quantbot Technologies LP	43	$3.70K	0.00%
Lindbrook Capital, LLC	7	$602	0.00%

Sold out (9)

Institutions that held Utah Medical Products Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of UTMD in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Bank of Montreal	12,292	$1.23M
Annex Advisory Services, LLC	3,526	$328.7K
Squarepoint Ops LLC	3,226	$300.7K
Captrust Financial Advisors	3,188	$297.1K
Watershed Asset Management, L.L.C.	2,515	$234.4K
Legato Capital Management LLC	2,416	$225.2K
Roffman Miller Associates Inc	50	$4.66K
Steward Partners Investment Advisory, LLC	31	$2.89K
GWM Advisors LLC	28	$2.61K